Alzheimer drugs for mild cognitive impairment?;Alzheimer - Medikamente bei mild cognitive impairment?

Neuropsychiatrie

Volumn 21, Issue 3, 2007, Pages 230-233

  Fellgiebel, Andreas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cholinesterase inhibitors; MCI; Memantine; Pharmacological treatment

Indexed keywords

CHOLINESTERASE INHIBITOR; GALANTAMINE; MEMANTINE; NOOTROPIC AGENT;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; HUMAN; OUTCOME ASSESSMENT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; AGED; EARLY DIAGNOSIS; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; TREATMENT FAILURE;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; EARLY DIAGNOSIS; GALANTAMINE; HUMANS; MEMANTINE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; TREATMENT FAILURE;

EID: 35648944799     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A. and Wilson, R. S.: Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64 834-841, (2005).
2. Birks, J. and Flicker, L.: Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 3 CD006104, (2006).
3. DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H. and Mufson, E. J.: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 51 145-155, (2002).
4. Feldman, H. H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., He, Y., Tekin, S., Burns, A., Cummings, J., del Ser, T., Inzitari, D., Orgogozo, J. M., Sauer, H., Scheltens, P., Scarpini, E.,, Herrmann, N., Farlow, M., Potkin, S., Charles, H. C., Fox, N. C. and Lane, R.: Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InD-Dex study. Lancet Neurol 6, 501-512 (2007).
5. Ganguli, M., Dodge, H. H., Shen, C. and DeKosky, S. T.: Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63 115-121, (2004).
6. Ikonomovic, M. D., Mufson, E. J., Wuu, J., Cochran, E. J., Bennett, D. A. and DeKosky, S. T.: Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis 5 39-48, (2003).
7. Jicha, G. A., Parisi, J. E., Dickon, D. W., Johnson, K., Cha, R., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., Knopman, D. S., Braak, H. and Petersen, R. C.: Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 63 674-681, (2006).
8. Loy, C. and Schneider, L.: Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev CD001747, (2006).
9. Maidment, I., Fox, C. and Boustani, M.: Cholinesterase inhibitors for Parkinson's disease dementia. Cochrane Database Syst Rev CD004747, (2006).
10. Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D. and Wekstein, D. R.: Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63 38-46, (2006).
11. Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H. and Berg, L.: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58 397-405, (2001).
12. Pappas, B. A., Bayley, P. J., Bui, B. K., Hansen, L. A. and Thal, L. J.: Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiol Aging 21 11-17, (2000).
13. Petersen, R. C.: Mild cognitive impairment as a diagnostic entity. J Intern Med 256 183-194, (2004).
14. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E.: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 303-308, (1999).
15. Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C. H. and Thal, L. J.: Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352 2379-2388, (2005).
16. Rasquin, S. M., Ladder, J., Visser, P. J., Lousberg, R. and Verhey, F. R.: Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study. Dement Geriatr Cogn Disord 19 113-119, (2005).
17. Roman, G. C., Wilkinson, D. G., Doody, R. S., Black, S. E., Salloway S. P. and Schindler, R. J.: Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord 20 338-344, (2005).
18. Salloway, S., Ferris, S., Kluger, A., Goldman, R., Griesing, T., Kumar, D. and Richardson, S.: Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 63 651-657, (2004).
19. Tabert, M. H., Manly, J. J., Liu, X., Pelton, G. H., Rosenblum, S., Jacobs, M., Zamora, D., Goodkind, M., Bell, K., Stern, Y. and Devanand, D. P.: Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 63 916-924, (2006).
20. Yesavage, J. A., Mumenthaler, M. S., Taylor, J. L., Friedman, L., O'Hara, R., Sheikh, J., Tinklenberg, J. and Whitehouse, P. J.: Donepezil and flight simulator performance: effects on retention of complex skills. Neurology 59 123-125, (2002).